Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
A randomized clinical trial of valacyclovir in multiple sclerosis.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Long-term Analyses of Innervation and Neuromuscular Integrity in the Trembler-J Mouse Model of Charcot-Marie-Tooth Disease.
Nrf2 in health and disease: current and future clinical implications.
Bioinformatics challenges for genome-wide association studies.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Severe dystonia as the first manifestation of neuromyelitis optica.
The effect of an AFO-shaped elastic band on drop-foot gait in patients with central neurological lesions.
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
Neuropathic pruritus (itch) in neuromyelitis optica.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Pages
« first
‹ previous
…
233
234
235
236
237
238
239
240
241
…
next ›
last »